Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 12445060)

Published in Br J Surg on December 01, 2002

Authors

M Ohtsuka1, H Ito, F Kimura, H Shimizu, A Togawa, H Yoshidome, M Miyazaki

Author Affiliations

1: Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, Chiba 260-8670, Japan.

Articles citing this

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer (2007) 2.09

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg (2008) 1.65

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol (2015) 1.55

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver (2009) 1.43

Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol (2004) 1.29

Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today (2011) 1.29

Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18

Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg (2007) 1.05

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00

Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol (2005) 0.98

Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol (2011) 0.97

New insights on cholangiocarcinoma. World J Gastrointest Oncol (2010) 0.94

Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol (2013) 0.91

Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.90

Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2008) 0.90

Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol (2015) 0.89

Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg (2011) 0.88

Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford) (2011) 0.88

Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterol Res Pract (2015) 0.87

Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86

Factors affecting survival after resection of intrahepatic cholangiocarcinoma. Surg Today (2014) 0.85

Surgical management of proximal bile duct cancers. Langenbecks Arch Surg (2012) 0.83

Staging laparoscopy for cholangiocarcinoma. HPB (Oxford) (2008) 0.83

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell Int (2013) 0.83

C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol (2006) 0.83

Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma. Can J Gastroenterol (2011) 0.82

Cholangiocarcinoma: has there been any progress? Can J Gastroenterol (2010) 0.82

Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One (2013) 0.82

Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Oncol (2015) 0.82

Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Oncotarget (2014) 0.81

Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling. BMC Clin Pathol (2014) 0.81

Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol (2015) 0.80

The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol (2015) 0.80

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. Onco Targets Ther (2015) 0.79

Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection. World J Surg (2014) 0.79

Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model. Clin Exp Med (2013) 0.79

STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Oncotarget (2016) 0.78

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma. PLoS One (2013) 0.78

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma. Drug Des Devel Ther (2014) 0.78

Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78

Serum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinoma. Int J Clin Exp Med (2015) 0.77

Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies. Clin Med Insights Oncol (2016) 0.77

Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma. Cancer Gene Ther (2015) 0.76

Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases. Front Oncol (2011) 0.76

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection. Dis Markers (2015) 0.76

MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma. Sci Rep (2017) 0.75

Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today (2011) 0.75

The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma. Oncotarget (2015) 0.75

Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass. Surg Today (2012) 0.75

Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis. PLoS One (2016) 0.75

Staging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr (2017) 0.75

Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. J Gastroenterol (2006) 0.75

Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol (2017) 0.75

Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy. J Gastroenterol (2012) 0.75

Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. Semin Intervent Radiol (2017) 0.75

The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis. J Cancer Res Clin Oncol (2017) 0.75

Articles by these authors

Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26

Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90

Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 8.64

THE ETIOLOGY, MODE OF INFECTION, AND SPECIFIC THERAPY OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 8.21

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med (2000) 6.68

PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol (1996) 6.68

Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support. Nucleic Acids Res (1982) 6.38

A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00

Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98

Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med (2000) 5.64

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 5.49

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36

Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med (1990) 4.88

Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38

PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis (2004) 4.33

THE PROPHYLAXIS OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 4.33

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99

THE RAT AS A CARRIER OF SPIROCHAETA ICTEROHAEMORRHAGIAE, THE CAUSATIVE AGENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1917) 3.80

Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature (1985) 3.59

THE SERUM TREATMENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 3.24

Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17

Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene (1994) 3.08

IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08

Studies on the mass receptor potential of the isolated frog retina. II. On the basis of the ionic mechanism. Vision Res (1969) 2.91

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer (2010) 2.82

Polypeptide chain elongation factor 1 alpha (EF-1 alpha) from yeast: nucleotide sequence of one of the two genes for EF-1 alpha from Saccharomyces cerevisiae. EMBO J (1984) 2.77

Effects of the complete removal of basic amino acid residues from the signal peptide on secretion of lipoprotein in Escherichia coli. J Biol Chem (1983) 2.66

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54

Fas ligand in human serum. Nat Med (1996) 2.53

Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48

Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol Cell Biol (1993) 2.48

Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol (1995) 2.47

Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology (2000) 2.37

Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet (1994) 2.36

Chlorophyll a oxygenase (CAO) is involved in chlorophyll b formation from chlorophyll a. Proc Natl Acad Sci U S A (1998) 2.35

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis (2001) 2.30

Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res (1994) 2.29

A large family of class III plant peroxidases. Plant Cell Physiol (2001) 2.21

Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines. Proc Natl Acad Sci U S A (1970) 2.19

Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes. EMBO J (1997) 2.19

A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol (2000) 2.16

Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis (1999) 2.16

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16

Studies on the nucleotide sequence of pseudouridine-containing 5S RNA from Saccharomyces cerevisiae. J Biochem (1974) 2.15

Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem (2001) 2.14

A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain. J Neurochem (1969) 2.13

Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11

Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09

Keratosis follicularis squamosa (Dohi): a follicular keratotic disorder well known in Japan. Br J Dermatol (2001) 2.01

Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (1996) 2.00

Formation of the male-specific muscle in female Drosophila by ectopic fruitless expression. Nat Cell Biol (2000) 1.99

Studies on the mass receptor potential of the isolated frog retina. I. General properties of the response. Vision Res (1969) 1.97

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J Cell Biol (1999) 1.96

Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med (1999) 1.95

Eccrine porocarcinoma and Bowen's disease arising in a seborrhoeic keratosis. Clin Exp Dermatol (2006) 1.95

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer (2006) 1.91

Demonstration of mother-to-infant transmission of hepatitis B virus by means of polymerase chain reaction. Lancet (1989) 1.90

Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology (1998) 1.90

New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol (1988) 1.85

Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob Agents Chemother (1997) 1.84

Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1999) 1.82

[Red free light magnifying photography in neuritis and some retinal vascular lesions]. Nihon Ganka Kiyo (1969) 1.81

Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care (1999) 1.78

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77

Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell Immunol (1980) 1.76

Reliability and validity of a questionnaire for assessment of energy expenditure and physical activity in epidemiological studies. J Epidemiol (1998) 1.76

Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel. Nature (1989) 1.74

Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill (2015) 1.73

Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole. Anesthesiology (1998) 1.73

Characterization of pyridoxine auxotrophs of Escherichia coli: serine and pdxF mutants. J Bacteriol (1970) 1.72

Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene (1998) 1.70

Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord (1995) 1.70

Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int (2006) 1.70

A role for reactive oxygen species in endothelial cell anoikis. Circ Res (1999) 1.69

Primary sequence of tRNA-Val-1 from Escherichia coli B. II. Isolation of large fragments by limited digestion with RNases, and overlapping of fragments to reduce the total primary sequence. Biochemistry (1971) 1.68

Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav (1999) 1.68

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67

Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67

CIRCULATING IMMUNITY PRINCIPLES IN RAT-BITE FEVER. J Exp Med (1917) 1.64

Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64

Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63

The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol (1997) 1.63

Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. Proc Natl Acad Sci U S A (2000) 1.62

Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62

Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62

A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun (2000) 1.62

Deoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett (1996) 1.61

Identification of species and capsular types of Klebsiella clinical isolates, with special reference to Klebsiella planticola. Microbiol Immunol (1989) 1.60

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60

Chymase-dependent angiotensin II formation in human vascular tissue. Circulation (1999) 1.60

Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.60

Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County. J Natl Cancer Inst (1987) 1.59